Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02783651 · ClinicalTrials.gov registry record
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
A clinical trial, sponsored by Amgen.
- Completed
- Registry status
- 212
- Enrollment target
NCT02783651 is a clinical trial that has completed, run by Amgen. The registered enrollment target is 212 participants.
The verdict
NCT02783651 has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- 212 participants
- Enrollment target
Study Summary
A retrospective chart review study of Philadelphia chromosome-negative R/R ALL patients in the US.
Interventions
- OTHER Other
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2016-06-30 |
| Est. Completion | 2020-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02783651
The ClinicalTrials.gov registry entry for NCT02783651 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Other is the first listed.
NCT02783651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02783651 about?
NCT02783651 is a clinical study titled "An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US". A retrospective chart review study of Philadelphia chromosome-negative R/R ALL patients in the US.
What is the current status of trial NCT02783651?
This trial is currently completed. The enrollment target is 212 participants. The study started on 2016-06-30. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT02783651?
The interventions under investigation include: Other (OTHER).
Who is sponsoring clinical trial NCT02783651?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.